EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neurotransmitter Regulatory Networks: A New Perspective on Cancer Therapy

Xiaoyu Zhang iD, Jiaxin Cao, Yishu Zhang, Chuanxiong Li, Yuhong Jing

Biomolecules · 09.10.2025 · 15 (10) · 1429

DOI: 10.3390/biom15101429 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 09.10.2025. Verfasst von Xiaoyu Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Anatomy and Histology & Embryology, Neuroscience, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Neurotransmitter Agents, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 239 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gansu Province Joint Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, the scientific community has increasingly delved into the study of the interaction between the nervous system and tumors, revealing that the nervous system not only regulates bodily functions under physiological conditions, but also assumes a vital part in the emergence and progression of tumors. Research has demonstrated that the extensive neural network directly regulates tumor progression and can influence tumors by modulating the tumor microenvironment and immune system. Moreover, tumors induce neural networks to provide favorable conditions for their proliferation and metastasis. In the above process, neurotransmitters play a vital role. They directly act or bind to their receptor, activating various classical signaling pathways, among which are PI3K/AKT, MEK/ERK, and WNT/β-catenin, to facilitate tumor advancement. Therefore, this study systematically reviews the regulatory mechanisms of neurotransmitters and their receptors in the advancement of cancer, along with the utilization of targeted drugs. At the same time, we also analyzed that targeting specific receptor subtypes may produce more significant therapeutic effects in different types of cancer. Additionally, this research further explores the limitations of neurotransmitter-based drugs currently used in clinical cancer treatment. In summary, the field of cancer neuroscience is rapidly advancing, constantly revealing the regulatory effects of neurotransmitters on tumor progression and their specific molecular mechanisms, providing broad application prospects for future clinical therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurotransmitter AgentsNeoplasmsHumansAnimalsSignal TransductionTumor MicroenvironmentAntineoplastic Agents

Stichwörter der Autor:innen

PI3K/AKT pathwaycancer neuroscienceneural signalingneurotransmittersreceptortargeted therapy

Substanzen

Neurotransmitter AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • Institute of Anatomy and Histology & Embryology, Neuroscience, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
  • Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Lanzhou University, Lanzhou 730000, China.

ORCID-Profile: Xiaoyu Zhang

Förderung

  • Gansu Province Joint Research Fund

Zitieren

APA

Zhang, X., Cao, J., Zhang, Y., Li, C., & Jing, Y. (2025). Neurotransmitter Regulatory Networks: A New Perspective on Cancer Therapy. Biomolecules, 15(10), 1429. https://doi.org/10.3390/biom15101429

Vancouver

Zhang X, Cao J, Zhang Y, Li C, Jing Y. Neurotransmitter Regulatory Networks: A New Perspective on Cancer Therapy. Biomolecules. 2025;15(10):1429. doi:10.3390/biom15101429

BibTeX
@article{Zhang2025,
  author = {Zhang, Xiaoyu and Cao, Jiaxin and Zhang, Yishu and Li, Chuanxiong and Jing, Yuhong},
  title = {Neurotransmitter Regulatory Networks: A New Perspective on Cancer Therapy},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {10},
  pages = {1429},
  doi = {10.3390/biom15101429}
}
Kostenlos starten →